Dezima Pharma Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Dezima Pharma General Information
Description
Developer of novel drugs intended to treat dyslipidemic patients suffering from cardiovascular disease. The company develops a cholesteryl ester transfer protein inhibitor that acts as a pharmacological therapy to lower low-density lipoprotein cholesterol and hence lower cardiovascular disease, thereby enabling clinicians to treat dyslipidemic patients.
Contact Information
Website
www.dezimapharma.comCorporate Office
- Gooimeer 2 - 35
- 1411 DC Naarden
- Netherlands
Corporate Office
- Gooimeer 2 - 35
- 1411 DC Naarden
- Netherlands
Dezima Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dezima Pharma Comparisons
Industry
Financing
Details
Dezima Pharma Competitors (17)
One of Dezima Pharma’s 17 competitors is The Zambon Group, a Private Debt Financed company based in Bresso, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Enterprise Therapeutics | Venture Capital-Backed | Brighton, United Kingdom |
Dezima Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Dezima Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Dezima Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Dezima Pharma FAQs
-
When was Dezima Pharma founded?
Dezima Pharma was founded in 2012.
-
Where is Dezima Pharma headquartered?
Dezima Pharma is headquartered in Naarden, Netherlands.
-
What is the size of Dezima Pharma?
Dezima Pharma has 1 total employees.
-
What industry is Dezima Pharma in?
Dezima Pharma’s primary industry is Drug Discovery.
-
Is Dezima Pharma a private or public company?
Dezima Pharma is a Private company.
-
What is Dezima Pharma’s current revenue?
The current revenue for Dezima Pharma is .
-
How much funding has Dezima Pharma raised over time?
Dezima Pharma has raised $19M.
-
Who are Dezima Pharma’s investors?
Amgen, BioGeneration Ventures, Forbion, and New Science Ventures have invested in Dezima Pharma.
-
Who are Dezima Pharma’s competitors?
The Zambon Group, Ability Pharma, Gilead, Genentech, and Enterprise Therapeutics are some of the 17 competitors of Dezima Pharma.
-
When was Dezima Pharma acquired?
Dezima Pharma was acquired on 01-Apr-2020.
-
Who acquired Dezima Pharma?
Dezima Pharma was acquired by NewAmsterdam Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
